About this trial
The goal of this cross-over clinical trial is to evaluate whether Neonatologist-Performed Lung Ultrasound (NPLUS) can be used in preterm babies on non-invasive breathing support to reduce the amount of oxygen they need. The main question it aims to answer is:
When a baby's oxygen requirement goes up, does NPLUS help to target interventions and reduce oxygen requirements?
Researchers will compare NPLUS to standard treatment.
Participants will:
Have a lung ultrasound performed whenever their oxygen requirement increases by more than 10%.
The ultrasound findings will be used to target interventions that aim to improve air entry in the lungs.
Each time this happens, the researchers will note what happens to the oxygen requirement afterwards.
Each participant will participate for five days. For the first two days, they will be randomized to either the NPLUS arm or the usual care arm.
There is then a 24 hour period of usual care. For the final two days, participants cross over to the other arm of the trial.
Eligibility criteria
Qualifiers
All preterm infants (<33 weeks gestational age) from their 2nd week of life, receiving respiratory support via NCPAP
expected to stay on NCPAP for the following 5 days at the NICU, Royal Hospital for Women, Randwick, Sydney
provided written informed consent obtained from parents.
Disqualifiers
Neonates with previous abdominal surgery
Major congenital anomalies.
>33+0 weeks
Less than 1 week of age
Trial design
Treatments tested in this trial
- Neonatologist performed lung ultrasound
Treatment groups
Sponsors and collaborators
Royal Hospital For Women
Lead sponsor
Medical University of Graz
Collaborator